Noticias de ANTX_US

Mercado

Noticias del mercado

Últimas noticias sobre ANTX_US — 125 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ANTX_US ✕ 125 resultados
20/09/2026 ANTX_US — MarketScreener
AN2 Therapeutics, Inc.(NasdaqGS: ANTX) added to S&P Global BMI Index
19/09/2026 ANTX_US — Traders Union
AN2 Therapeutics, Inc. (ANTX) Stock Price History & Data
17/09/2026 ANTX_US — The National Law Review
AN2 Therapeutics, Inc. Reports Inducement Grants under Listing Rule 5635(c)(4)
17/09/2026 ANTX_US — BioSpace
AN2 Therapeutics, Inc. Reports Inducement Grants under Listing Rule 5635(c)(4) - September 16, 2026
16/09/2026 ANTX_US — Business Wire
AN2 Therapeutics, Inc. Reports Inducement Grants under Listing Rule 5635(c)(4)
16/09/2026 ANTX_US — Stock Titan
AN2 Therapeutics (ANTX) awards stock and options to its chief medical officer
16/09/2026 ANTX_US — Yahoo Finance
AN2 Therapeutics, Inc. Reports Inducement Grants under Listing Rule 5635(c)(4)
14/09/2026 ANTX_US — Kalkine Media
AN2 Therapeutics Insider Readnour Robin Shane Sells 1,108 Shares at $6.02 Each (NASDAQ: ANTX)
12/09/2026 ANTX_US — Investing.com
An2 therapeutics director Robin Readnour sells $6,674 in shares By Investing.com
11/09/2026 ANTX_US — Investing.com
An2 therapeutics director Robin Readnour sells $6,674 in shares By Investing.com
11/09/2026 ANTX_US — Investing.com
An2 therapeutics director Robin Readnour sells $6,674 in shares By Investing.com
11/09/2026 ANTX_US — Investing.com
An2 therapeutics director Robin Readnour sells $6,674 in shares By Investing.com
11/09/2026 ANTX_US — Investing.com
An2 therapeutics director Robin Readnour sells $6,674 in shares By Investing.com
11/09/2026 ANTX_US — Investing.com
An2 therapeutics director Robin Readnour sells $6,674 in shares By Investing.com
11/09/2026 ANTX_US — Stock Titan
AN2 Therapeutics (ANTX) director sells 1,108 shares under preset plan
11/09/2026 ANTX_US — Investing.com
An2 therapeutics director Robin Readnour sells $6,674 in shares
11/09/2026 ANTX_US — Bitget
AN2 Therapeutics director Robin Shane Readnour disposes of 1,108 common shares worth $6,675

Director Robin Shane Readnour reported indirect sales of 1,108 AN2 Therapeutics common shares on Sep. 9, 2026. Transactions priced at a weighte | Bitget crypto news!

09/09/2026 ANTX_US — Investing.com
An2 therapeutics director Robin Readnour sells $97,322 in shares By Investing.com
09/09/2026 ANTX_US — Investing.com
An2 therapeutics director Robin Readnour sells $97,322 in shares By Investing.com
08/09/2026 ANTX_US — Investing.com
An2 therapeutics director Robin Readnour sells $97,322 in shares By Investing.com

Página 3 de 7